Breast and prostate cancer risk: the interplay of polygenic risk, high-impact monogenic variants, and family history
View ORCID ProfileEmadeldin Hassanin, View ORCID ProfilePatrick May, View ORCID ProfileRana Aldisi, Isabel Spier, View ORCID ProfileAndreas J. Forstner, View ORCID ProfileMarkus M. Nöthen, Stefan Aretz, View ORCID ProfilePeter Krawitz, Dheeraj Reddy Bobbili, View ORCID ProfileCarlo Maj
doi: https://doi.org/10.1101/2021.06.04.21258277
Emadeldin Hassanin
1Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany
Patrick May
2Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
Rana Aldisi
1Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany
Isabel Spier
3Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
4National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Germany
Andreas J. Forstner
3Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
5Centre for Human Genetics, University of Marburg, Marburg, Germany
6Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany
Markus M. Nöthen
3Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
Stefan Aretz
3Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
4National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Germany
Peter Krawitz
1Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany
Dheeraj Reddy Bobbili
2Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
Carlo Maj
1Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany
Article usage
Posted June 09, 2021.
Breast and prostate cancer risk: the interplay of polygenic risk, high-impact monogenic variants, and family history
Emadeldin Hassanin, Patrick May, Rana Aldisi, Isabel Spier, Andreas J. Forstner, Markus M. Nöthen, Stefan Aretz, Peter Krawitz, Dheeraj Reddy Bobbili, Carlo Maj
medRxiv 2021.06.04.21258277; doi: https://doi.org/10.1101/2021.06.04.21258277
Breast and prostate cancer risk: the interplay of polygenic risk, high-impact monogenic variants, and family history
Emadeldin Hassanin, Patrick May, Rana Aldisi, Isabel Spier, Andreas J. Forstner, Markus M. Nöthen, Stefan Aretz, Peter Krawitz, Dheeraj Reddy Bobbili, Carlo Maj
medRxiv 2021.06.04.21258277; doi: https://doi.org/10.1101/2021.06.04.21258277
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2692)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12326)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4164)
- Geriatric Medicine (392)
- Health Economics (688)
- Health Informatics (2702)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3947)
- Nursing (214)
- Nutrition (587)
- Oncology (2076)
- Ophthalmology (596)
- Orthopedics (244)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1133)
- Primary Care Research (462)
- Public and Global Health (6590)
- Radiology and Imaging (1428)
- Respiratory Medicine (877)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)